unresectable stage iii nsclc
Showing 1 - 2 of 2
Unresectable Stage III NSCLC Trial in Zhengzhou, Shanghai (Durvalumab, Carboplatin/ Paclitaxel, Pemetrexed/ Cisplatin)
Recruiting
- Unresectable Stage III NSCLC
- Durvalumab
- +4 more
-
Zhengzhou, Henan, China
- +1 more
Aug 1, 2021
Endostar Combined With Concurrent Radiochemotherapy for
Not yet recruiting
- Unresectable Stage III NSCLC
- (no location specified)
Nov 12, 2019